Universal Health Services, Inc. (0LJL.L)
USD 181.27
(-0.29%)
USD 181.27
(-0.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 717.79 Million USD | 6.24% |
| 2022 | 675.6 Million USD | -31.87% |
| 2021 | 991.59 Million USD | 5.05% |
| 2020 | 943.95 Million USD | 15.84% |
| 2019 | 814.85 Million USD | 4.51% |
| 2018 | 779.7 Million USD | 3.64% |
| 2017 | 752.3 Million USD | 7.1% |
| 2016 | 702.4 Million USD | 3.22% |
| 2015 | 680.52 Million USD | 24.79% |
| 2014 | 545.34 Million USD | 6.78% |
| 2013 | 510.73 Million USD | 15.17% |
| 2012 | 443.44 Million USD | 11.37% |
| 2011 | 398.16 Million USD | 72.98% |
| 2010 | 230.18 Million USD | -11.59% |
| 2009 | 260.37 Million USD | 30.59% |
| 2008 | 199.37 Million USD | 17.01% |
| 2007 | 170.38 Million USD | -34.33% |
| 2006 | 259.45 Million USD | 7.73% |
| 2005 | 240.84 Million USD | 42.1% |
| 2004 | 169.49 Million USD | -14.94% |
| 2003 | 199.26 Million USD | 13.63% |
| 2002 | 175.36 Million USD | 75.81% |
| 2001 | 99.74 Million USD | 6.83% |
| 2000 | 93.36 Million USD | 20.0% |
| 1999 | 77.8 Million USD | -2.26% |
| 1998 | 79.6 Million USD | 18.28% |
| 1997 | 67.3 Million USD | 32.74% |
| 1996 | 50.7 Million USD | 42.82% |
| 1995 | 35.5 Million USD | 23.69% |
| 1994 | 28.7 Million USD | 19.58% |
| 1993 | 24 Million USD | 20.0% |
| 1992 | 20 Million USD | -1.48% |
| 1991 | 20.3 Million USD | 75.0% |
| 1990 | 11.6 Million USD | 28.89% |
| 1989 | 9 Million USD | 40.63% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 289.15 Million USD | 10.43% |
| 2024 Q3 | 258.71 Million USD | -10.53% |
| 2024 Q1 | 261.83 Million USD | 21.01% |
| 2023 Q3 | 166.98 Million USD | -2.52% |
| 2023 Q1 | 163.11 Million USD | -6.7% |
| 2023 Q2 | 171.31 Million USD | 5.03% |
| 2023 FY | 717.79 Million USD | 6.24% |
| 2023 Q4 | 216.37 Million USD | 29.58% |
| 2022 Q2 | 163.89 Million USD | 6.66% |
| 2022 Q4 | 174.82 Million USD | -4.28% |
| 2022 FY | 675.6 Million USD | -31.87% |
| 2022 Q1 | 153.66 Million USD | -35.62% |
| 2022 Q3 | 182.63 Million USD | 11.43% |
| 2021 Q2 | 324.36 Million USD | 55.54% |
| 2021 Q1 | 208.53 Million USD | -32.23% |
| 2021 Q3 | 217.95 Million USD | -32.81% |
| 2021 FY | 991.59 Million USD | 5.05% |
| 2021 Q4 | 238.67 Million USD | 9.51% |
| 2020 Q1 | 141.66 Million USD | -42.07% |
| 2020 Q4 | 307.71 Million USD | 27.95% |
| 2020 Q3 | 240.48 Million USD | -4.23% |
| 2020 Q2 | 251.1 Million USD | 77.25% |
| 2020 FY | 943.95 Million USD | 15.84% |
| 2019 Q2 | 237.66 Million USD | 1.72% |
| 2019 Q1 | 233.65 Million USD | 48.07% |
| 2019 FY | 814.85 Million USD | 4.51% |
| 2019 Q3 | 96.94 Million USD | -59.21% |
| 2019 Q4 | 244.56 Million USD | 152.26% |
| 2018 Q4 | 157.79 Million USD | -7.95% |
| 2018 FY | 779.7 Million USD | 3.64% |
| 2018 Q2 | 225.66 Million USD | 0.86% |
| 2018 Q1 | 223.72 Million USD | 1.92% |
| 2018 Q3 | 171.42 Million USD | -24.03% |
| 2017 FY | 752.3 Million USD | 7.1% |
| 2017 Q3 | 141.08 Million USD | -23.87% |
| 2017 Q4 | 219.5 Million USD | 55.59% |
| 2017 Q2 | 185.31 Million USD | -10.03% |
| 2017 Q1 | 205.96 Million USD | 18.28% |
| 2016 Q2 | 185.49 Million USD | -2.72% |
| 2016 Q4 | 174.13 Million USD | 14.72% |
| 2016 FY | 702.4 Million USD | 3.22% |
| 2016 Q1 | 190.67 Million USD | 9.78% |
| 2016 Q3 | 151.79 Million USD | -18.17% |
| 2015 Q2 | 182.12 Million USD | 4.53% |
| 2015 FY | 680.52 Million USD | 24.79% |
| 2015 Q3 | 150.2 Million USD | -17.53% |
| 2015 Q4 | 173.68 Million USD | 15.63% |
| 2015 Q1 | 174.23 Million USD | 0.87% |
| 2014 Q3 | 82.78 Million USD | -45.39% |
| 2014 Q2 | 151.59 Million USD | 9.84% |
| 2014 Q1 | 138 Million USD | 10.91% |
| 2014 FY | 545.34 Million USD | 6.78% |
| 2014 Q4 | 172.72 Million USD | 108.66% |
| 2013 Q2 | 151.75 Million USD | 26.76% |
| 2013 Q1 | 119.71 Million USD | -11.55% |
| 2013 FY | 510.73 Million USD | 15.17% |
| 2013 Q4 | 124.42 Million USD | 8.63% |
| 2013 Q3 | 114.54 Million USD | -24.52% |
| 2012 Q3 | 71.73 Million USD | -33.23% |
| 2012 Q1 | 128.43 Million USD | 34.81% |
| 2012 Q4 | 135.34 Million USD | 88.68% |
| 2012 FY | 443.44 Million USD | 11.37% |
| 2012 Q2 | 107.43 Million USD | -16.35% |
| 2011 Q2 | 103.52 Million USD | -9.23% |
| 2011 Q1 | 114.04 Million USD | 206.72% |
| 2011 Q3 | 84.88 Million USD | -18.0% |
| 2011 Q4 | 95.27 Million USD | 12.23% |
| 2011 FY | 398.16 Million USD | 72.98% |
| 2010 Q3 | 55.61 Million USD | -15.19% |
| 2010 FY | 230.18 Million USD | -11.59% |
| 2010 Q4 | 37.18 Million USD | -33.14% |
| 2010 Q1 | 71.81 Million USD | 18.0% |
| 2010 Q2 | 65.57 Million USD | -8.7% |
| 2009 Q2 | 80.89 Million USD | 19.77% |
| 2009 FY | 260.37 Million USD | 30.59% |
| 2009 Q4 | 60.86 Million USD | 19.17% |
| 2009 Q3 | 51.07 Million USD | -36.86% |
| 2009 Q1 | 67.54 Million USD | 45.32% |
| 2008 Q2 | 66.61 Million USD | 8.03% |
| 2008 Q1 | 61.66 Million USD | 54.33% |
| 2008 FY | 199.37 Million USD | 17.01% |
| 2008 Q3 | 36.98 Million USD | -44.48% |
| 2008 Q4 | 46.47 Million USD | 25.66% |
| 2007 FY | 170.38 Million USD | -34.33% |
| 2007 Q4 | 39.95 Million USD | 38.56% |
| 2007 Q1 | 49.5 Million USD | 44.89% |
| 2007 Q2 | 52.07 Million USD | 5.18% |
| 2007 Q3 | 28.83 Million USD | -44.62% |
| 2006 FY | 259.45 Million USD | 7.73% |
| 2006 Q3 | 113.94 Million USD | 89.09% |
| 2006 Q1 | 51.08 Million USD | 316.2% |
| 2006 Q2 | 60.25 Million USD | 17.96% |
| 2006 Q4 | 34.17 Million USD | -70.01% |
| 2005 FY | 240.84 Million USD | 42.1% |
| 2005 Q4 | 12.27 Million USD | 47.54% |
| 2005 Q3 | 8.31 Million USD | -94.76% |
| 2005 Q2 | 158.84 Million USD | 158.66% |
| 2005 Q1 | 61.4 Million USD | 65.19% |
| 2004 FY | 169.49 Million USD | -14.94% |
| 2004 Q2 | 48.28 Million USD | 4.56% |
| 2004 Q3 | 37.84 Million USD | -21.63% |
| 2004 Q4 | 37.17 Million USD | -1.77% |
| 2004 Q1 | 46.18 Million USD | -0.61% |
| 2003 Q2 | 50.95 Million USD | -3.49% |
| 2003 Q3 | 49.06 Million USD | -3.71% |
| 2003 FY | 199.26 Million USD | 13.63% |
| 2003 Q4 | 46.46 Million USD | -5.29% |
| 2003 Q1 | 52.79 Million USD | 20.28% |
| 2002 Q4 | 43.89 Million USD | 5.88% |
| 2002 FY | 175.36 Million USD | 75.81% |
| 2002 Q1 | 45.67 Million USD | 4826.97% |
| 2002 Q2 | 44.34 Million USD | -2.9% |
| 2002 Q3 | 41.45 Million USD | -6.53% |
| 2001 Q3 | 30.25 Million USD | -6.59% |
| 2001 Q2 | 32.39 Million USD | -10.45% |
| 2001 Q4 | 927 Thousand USD | -96.94% |
| 2001 FY | 99.74 Million USD | 6.83% |
| 2001 Q1 | 36.17 Million USD | 89.49% |
| 2000 Q4 | 19.08 Million USD | -14.53% |
| 2000 Q1 | 28.62 Million USD | 104.49% |
| 2000 Q2 | 23.3 Million USD | -18.58% |
| 2000 Q3 | 22.33 Million USD | -4.18% |
| 2000 FY | 93.36 Million USD | 20.0% |
| 1999 Q2 | 23 Million USD | -23.33% |
| 1999 Q1 | 30 Million USD | 48.51% |
| 1999 FY | 77.8 Million USD | -2.26% |
| 1999 Q4 | 14 Million USD | 29.63% |
| 1999 Q3 | 10.8 Million USD | -53.04% |
| 1998 Q1 | 25.7 Million USD | 71.33% |
| 1998 FY | 79.6 Million USD | 18.28% |
| 1998 Q3 | 13.4 Million USD | -34.63% |
| 1998 Q4 | 20.2 Million USD | 50.75% |
| 1998 Q2 | 20.5 Million USD | -20.23% |
| 1997 Q4 | 15 Million USD | 8.7% |
| 1997 FY | 67.3 Million USD | 32.74% |
| 1997 Q1 | 21.5 Million USD | 83.76% |
| 1997 Q2 | 16.9 Million USD | -21.4% |
| 1997 Q3 | 13.8 Million USD | -18.34% |
| 1996 Q2 | 12.2 Million USD | -21.29% |
| 1996 Q1 | 15.5 Million USD | 124.64% |
| 1996 FY | 50.7 Million USD | 42.82% |
| 1996 Q4 | 11.7 Million USD | 3.54% |
| 1996 Q3 | 11.3 Million USD | -7.38% |
| 1995 Q2 | 9.6 Million USD | -18.64% |
| 1995 FY | 35.5 Million USD | 23.69% |
| 1995 Q4 | 6.9 Million USD | -4.17% |
| 1995 Q3 | 7.2 Million USD | -25.0% |
| 1995 Q1 | 11.8 Million USD | 168.18% |
| 1994 Q1 | 10.3 Million USD | 171.05% |
| 1994 Q2 | 8.2 Million USD | -20.39% |
| 1994 Q3 | 5.8 Million USD | -29.27% |
| 1994 Q4 | 4.4 Million USD | -24.14% |
| 1994 FY | 28.7 Million USD | 19.58% |
| 1993 Q2 | 6.5 Million USD | -24.42% |
| 1993 Q3 | 5.2 Million USD | -20.0% |
| 1993 Q4 | 3.8 Million USD | -26.92% |
| 1993 FY | 24 Million USD | 20.0% |
| 1993 Q1 | 8.6 Million USD | 186.67% |
| 1992 FY | 20 Million USD | -1.48% |
| 1992 Q4 | 3 Million USD | -11.76% |
| 1992 Q3 | 3.4 Million USD | -44.26% |
| 1992 Q2 | 6.1 Million USD | -17.57% |
| 1992 Q1 | 7.4 Million USD | 221.74% |
| 1991 Q3 | 2.5 Million USD | -56.9% |
| 1991 Q4 | 2.3 Million USD | -8.0% |
| 1991 Q2 | 5.8 Million USD | -40.21% |
| 1991 FY | 20.3 Million USD | 75.0% |
| 1991 Q1 | 9.7 Million USD | 781.82% |
| 1990 FY | 11.6 Million USD | 28.89% |
| 1990 Q2 | 3.5 Million USD | 0.0% |
| 1990 Q4 | 1.1 Million USD | -21.43% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | 1.4 Million USD | -60.0% |
| 1989 FY | 9 Million USD | 40.63% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 624.378% |
| Accuray Incorporated | -15.54 Million USD | 4717.53% |
| Align Technology, Inc. | 445.05 Million USD | -61.283% |
| Elevance Health Inc. | 5.98 Billion USD | 88.011% |
| AxoGen, Inc. | -21.71 Million USD | 3405.374% |
| Boston Scientific Corporation | 1.59 Billion USD | 54.941% |
| CVS Health Corporation | 8.34 Billion USD | 91.397% |
| Cardinal Health, Inc. | 852 Million USD | 15.752% |
| Centene Corporation | 2.7 Billion USD | 73.435% |
| DaVita Inc. | 691.53 Million USD | -3.797% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 86.307% |
| Hologic, Inc. | 789.5 Million USD | 9.082% |
| Humana Inc. | 2.48 Billion USD | 71.161% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 15.058% |
| Laboratory Corporation of America Holdings | 418 Million USD | -71.721% |
| Masimo Corporation | 81.5 Million USD | -780.73% |
| McKesson Corporation | 3 Billion USD | 76.089% |
| Patterson Companies, Inc. | 185.93 Million USD | -286.055% |
| Quest Diagnostics Incorporated | 854 Million USD | 15.949% |
| ResMed Inc. | 1.02 Billion USD | 29.693% |
| Henry Schein, Inc. | 416 Million USD | -72.547% |
| Teladoc Health, Inc. | -220.36 Million USD | 425.726% |
| Veeva Systems Inc. | 525.7 Million USD | -36.54% |
| Baxter International Inc. | 2.65 Billion USD | 72.975% |
| Becton, Dickinson and Company | 1.48 Billion USD | 51.631% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 60.078% |
| Danaher Corporation | 4.2 Billion USD | 82.91% |
| Stryker Corporation | 3.16 Billion USD | 77.321% |
| Medtronic plc | 3.67 Billion USD | 80.473% |